First Trust Latin America AlphaDEX Fund (NASDAQ:FLN – Get Free Report) saw a large decline in short interest in the month of January. As of January 15th, there was short interest totalling 700 shares, a decline of 80.0% from the December 31st total of 3,500 shares. Based on an average daily trading volume, of 9,300 shares, the short-interest ratio is currently 0.1 days.
Institutional Inflows and Outflows
An institutional investor recently raised its position in First Trust Latin America AlphaDEX Fund stock. Jane Street Group LLC grew its position in First Trust Latin America AlphaDEX Fund (NASDAQ:FLN – Free Report) by 27.7% in the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 69,053 shares of the company’s stock after acquiring an additional 14,960 shares during the period. Jane Street Group LLC owned about 6.91% of First Trust Latin America AlphaDEX Fund worth $1,246,000 at the end of the most recent quarter.
First Trust Latin America AlphaDEX Fund Price Performance
NASDAQ FLN traded up $0.26 during midday trading on Thursday, hitting $16.63. 6,736 shares of the company traded hands, compared to its average volume of 19,970. The company’s 50-day simple moving average is $15.89 and its 200-day simple moving average is $17.17. First Trust Latin America AlphaDEX Fund has a 52 week low of $15.03 and a 52 week high of $21.07. The company has a market cap of $14.14 million, a PE ratio of 5.99 and a beta of 1.09.
First Trust Latin America AlphaDEX Fund Company Profile
The First Trust Latin America AlphaDEX Fund (FLN) is an exchange-traded fund that is based on the NASDAQ AlphaDEX Latin America index. The fund tracks an index of Latin American firms screened based on a proprietary methodology, using various factors and weighted in tiers. FLN was launched on Apr 18, 2011 and is managed by First Trust.
Read More
- Five stocks we like better than First Trust Latin America AlphaDEX Fund
- Are Penny Stocks a Good Fit for Your Portfolio?
- Microsoft Stock Breaks Trend, But It Doesn’t Matter—Here’s Why
- 3 Warren Buffett Stocks to Buy Now
- How Value Investors Find Undervalued Stocks and Build Wealth
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Is Tonix Pharmaceuticals the Next Biotech Breakout?
Receive News & Ratings for First Trust Latin America AlphaDEX Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for First Trust Latin America AlphaDEX Fund and related companies with MarketBeat.com's FREE daily email newsletter.